Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With AdCh63 ME-TRAP and MVA ME-TRAP.

Trial Profile

Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With AdCh63 ME-TRAP and MVA ME-TRAP.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Nov 2012

At a glance

  • Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; ME-TRAP malaria DNA vaccine Okairos (Primary)
  • Indications Falciparum malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2011 Actual initiation date changed from Mar 2009 to Feb 2009 as reported by ClinicalTrials.gov.
    • 16 Nov 2011 New source identified and integrated (European Clinical Trials Database: EudraCT2008-006804-46).
    • 25 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top